L&T-TECHNOLOGY-SERVICES
L&T Technology Services Limited (BSE: 540115, NSE: LTTS), a leading global pure-play engineering services company, announced that it has been selected by a global O&G major to be the primary engineering partner to support two of their integrated refining and chemicals manufacturing facilities in USA. This is a multi-year engagement with a potential value of more than USD 100 Million.
Under the five-year engagement, LTTS will provide multi-discipline plant engineering activities including site sustenance, discipline engineering and control automation support for both facilities. LTTS will leverage its in-house digital engineering tools and new age technology & solutions to optimize project execution and drive efficiency improvements for the customer. The two sites covered under LTTS’ scope are integrated refining, chemical and polymer complexes and are currently among the top 10 biggest downstream sites in the U.S.
Dr. Keshab Panda, CEO & MD, L&T Technology Services, said , “Our focus on multi vertical, large engagements with customer intimacy, leveraging digital and new age technologies is yielding the desired outcomes. This latest instance of a major customer awarding LTTS a large multi-year program is testimony to our global plant engineering expertise.”
“ LTTS is delighted to partner with one of the world’s leading O&G companies who are focused on providing affordable & sustainable energy and chemical products. Having worked in the Oil & Gas industry for a long time, our engineers have a unique appreciation of the challenges and opportunities in the energy and chemical industry. This is a prestigious win for LTTS, and we are excited to engage with our customer to deliver value in improving operational efficiency,” Dr. Panda added.
About L&T Technology Services Ltd
L&T Technology Services Limited (LTTS) is a listed subsidiary of Larsen & Toubro Limited focused on Engineering and R&D (ER&D) services. We offer consultancy, design, development and testing services across the product and process development life cycle. Our customer base includes 69 Fortune 500 companies and 53 of the world’s top ER&D companies, across industrial products, medical devices, transportation, telecom & hi-tech, and the process industries. Headquartered in India, we have over 15,900 employees spread across 17 global design centers, 28 global sales offices and 52 innovation labs as of September 30, 2020. For more information please visit https://www.ltts.com/
View source version on businesswire.com: https://www.businesswire.com/news/home/20201209006093/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
DBS and Ant International Enhance Strategic Partnership to Scale Innovative Cross-Border Payment and Fintech Solutions to Drive Inclusive Growth13.11.2025 04:00:00 CET | Press release
MoU signed at the Singapore Fintech Festival 2025 covers several areas of strategic cooperation to scale digital payments, strengthen connectivity and advance fintech innovationPartnership enables DBS PayLah! users to scan Alipay+ QR codes to pay at more than 150 million merchants across over 100 markets DBS and Ant International have agreed to deepen their existing strategic collaboration to jointly explore innovative payments, digitisation and fintech solutions aimed at providing more inclusive services for regional businesses of all sizes and individual consumers. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20251112714266/en/ From left to right: Tan Su Shan, CEO of DBS, Loy Hwee Chuan, Segment Head of Telecommunications, Media & Tech, Hong Kong and GBA, DBS, Edward Yue, Alipay+ General Manager for SEA, ANZ and South Asia at Ant International, Peng Yang, CEO of Ant International The collaboration will leverage DBS’ digita
LabGenius Therapeutics Announces Poster Presentation at the ESMO Immuno-Oncology Congress 202513.11.2025 01:00:00 CET | Press release
LabGenius Therapeutics (“LabGenius”), a drug discovery company combining artificial intelligence (AI) and high-throughput experimentation to advance next-generation multispecific antibodies for solid tumours, today announced a scientific poster will be presented at the ESMO Immuno-Oncology Congress 2025, being held December 10 - 12, 2025, at the Queen Elizabeth II Centre in London, United Kingdom. LabGenius’ presentation will debut the pre-clinical in vivo efficacy (>90% tumour growth inhibition) and tolerability data for their lead asset, a highly tumour selective bispecific T-cell engager (TCE). Poster Presentation Details Title Novel Selectivity-Enhanced Bispecific T-cell Engager Utilises Avidity to Overcome On-target, Off-tumour Toxicity Date and time Wednesday, December 10, 2025, 08:00 (GMT) Poster number 309P Location The Churchill Room, Queen Elizabeth II Centre, London Bispecific TCE Overview For the selected target, LabGenius has developed a selectivity-enhanced TCE. The compa
VeriSilicon and Google Jointly Launch Open-Source Coral NPU IP13.11.2025 01:00:00 CET | Press release
Targeting edge LLM applications, accelerating edge AI ecosystem development VeriSilicon (688521.SH) recently announced the joint launch of the Coral NPU IP with Google, targeting always-on, ultra-low-energy edge Large Language Model (LLM) applications. The IP is based on Google’s foundational research in open machine learning compilers and enhanced with AI security features, providing developers with a unified open-source platform to build a robust edge AI ecosystem. The Coral NPU is built on the open RISC-V instruction set architecture, featuring native tensor processing capabilities, supporting mainstream machine learning frameworks such as JAX, PyTorch, and TensorFlow Lite (TFLite), and utilizing open-standard tools like Multi-Level Intermediate Representation (MLIR) from the Low Level Virtual Machine (LLVM) project for compiler infrastructure. It is designed for always-on, ultra-low-energy edge AI applications, particularly for wearable devices and ambient sensing systems. The Cora
Indero Announces Breakthrough Method for Early-Phase Evaluation of Topical Drugs Using Quantitative Gene Expression13.11.2025 00:00:00 CET | Press release
Indero is proud to announce the successful completion of an internally funded study that introduces a novel approach to evaluating topical new chemical entities (NCE) in early-phase clinical research. This innovative method leverages quantitative gene expression analysis to assess drug efficacy rapidly and cost effectively. Dr. Robert Bissonnette, Executive Chairman and Founder of Indero, who initiated and led the study, shared his excitement about the results: “Our goal was to rethink how to study topical drugs in early phase studies. The results of this study demonstrate that microdosing for only 3 days can provide meaningful efficacy signals. Within just 24 hours, we observed alterations in gene expression after applying a microdose of mid-potency corticosteroid on the skin of patients. By 72 hours, Th2, Th22 and Th17-specific biomarkers were significantly reduced. This outcome is exactly what we hoped for and opens the door to faster, smarter drug development strategies, demonstrat
Andersen Consulting styrker sine kompetencer inden for digital transformation gennem samarbejde med VaporVM12.11.2025 23:54:00 CET | Pressemeddelelse
Andersen Consulting udvider sine kompetencer inden for digital transformation og cybersikkerhed med tilføjelsen af samarbejdspartneren VaporVM, der er et cloud-native teknologifirma med hovedsæde i Dubai. VaporVM, der blev grundlagt i 2017, hjælper globale virksomheder med at navigere i digital transformation gennem integrerede cloud-tjenester, DevOps, cybersikkerhed, datavidenskab og modernisering af applikationer. Med fokus på skalerbarhed og hurtigere lanceringer arbejder firmaet med Fortune 500-virksomheder og udnytter deres ekspertise og automatisering til at effektivisere it-drift og fremskynde digitale resultater. "Hos VaporVM brænder vi for at hjælpe virksomheder med ikke bare at tage nye teknologier til sig, men også at gentænke, hvad der kan lade sig gøre, når de bruges til at skabe reel forandring," siger Aqeel Asim, der er CEO og grundlægger af VaporVM. "Samarbejdet med Andersen Consulting giver os mulighed for at løfte vores mission til et globalt niveau – så vi kan bringe
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom